Bhavesh Mohan Lal

Researcher

UAMS

Also affiliated: University of Arkansas Medical Center (2025); All India Institute of Medical Sciences (2021–2026)

Faculty Researcher

6 h-index 38 pubs 113 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Bhavesh Mohan Lal's research focuses on hematologic malignancies, particularly multiple myeloma, and the application of advanced therapies such as CAR-T cell therapy and bispecific antibodies. His work investigates treatment outcomes and influencing factors for patients with relapsed refractory multiple myeloma, including the impact of prior exposure to specific anti-cancer agents like belantamab mafodotin. Lal also contributes to the study of autoimmune diseases, conducting systematic reviews on conditions such as autoimmune encephalitis associated with COVID-19 and CAR-T cell therapy in autoimmune disease patients. His publications also extend to other clinical areas, including a retrospective study on pneumothorax and pneumomediastinum in COVID-19 patients and ultrasonography for obstructive sleep apnea. He has published 38 papers, with an h-index of 5 and 98 citations. Lal collaborates with several researchers at the University of Arkansas for Medical Sciences, including Toshali Pandey and Ankur Varma.

Metrics

h-index: 6
Publications: 38
Citations: 113

Selected Publications

Association Between Metabolic Syndrome and Prostate Cancer: A Systematic Review (2026)

Cancers DOI OpenAlex
Social vulnerability index as an independent poor prognostic factor in patients with chronic hematological malignancies in Arkansas. (2026)

Journal of Clinical Oncology DOI OpenAlex
New Approaches for Measurable Residual Disease Assessment in Multiple Myeloma: Integrating NGS, Mass Spectrometry, and Next-Generation Flow Cytometry to Monitor Treatment Response (2026)

Current Hematologic Malignancy Reports DOI OpenAlex
Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma (2026)

Blood Cancer Journal 1 citation DOI OpenAlex
Critical platelet shortages and a single Institution's experience with split platelet transfusions: Can you get by with just half a unit? (2025)

Blood DOI OpenAlex
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study (2025)

Blood Cancer Journal 14 citations DOI OpenAlex
Incidentally Detected Pulmonary Carcinoid Tumorlet With Coexisting Carcinoid Tumorlet in the Mediastinal Lymph Node in a Patient With Lung Cancer (2025)

Case Reports in Pulmonology DOI OpenAlex
International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings (2025)

JCO Oncology Practice 2 citations DOI OpenAlex
Prognostic significance of neutrophil-to-lymphocyte ratio in small cell lung cancer in the era of immunotherapy. (2025)

Journal of Clinical Oncology DOI OpenAlex
Impact of demographic and socioeconomic factors on survival outcomes in patients with Waldenstrom macroglobulinemia: A SEER database analysis from 2000-2021. (2025)

Journal of Clinical Oncology DOI OpenAlex
Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025)

Journal of Clinical Oncology DOI OpenAlex
Incidence and impact of incidental pulmonary embolism in solid cancer patients. (2025)

Journal of Clinical Oncology DOI OpenAlex
MRI lesion burden as a predictor of progression and survival in smoldering multiple myeloma. (2025)

Journal of Clinical Oncology DOI OpenAlex
NSCLC in the immunotherapy era: Trends in survival and disparities across demographic and socioeconomic groups. (2025)

Journal of Clinical Oncology 1 citation DOI OpenAlex
Patterns of mortality in lung cancer patients in the era of immunotherapy and targeted therapy: A single-center, retrospective, observational study. (2025)

Journal of Clinical Oncology DOI OpenAlex